Minister of Industry and Mineral Resources Lays Foundation Stone for Sudair Pharma’s Insulin Manufacturing Facility

Sudair Pharma was honored to welcome His Excellency the Minister of Industry and Mineral Resources during a special visit to lay the foundation stone for the company’s new insulin manufacturing facility—an important step in strengthening pharmaceutical localization and meeting national healthcare needs.
Sudair Pharma Signs Cooperation Agreement with the College of Pharmacy at Princess Nourah University to Advance Research and Pharmaceutical Innovation

Sudair Pharma has signed a cooperation agreement with the College of Pharmacy at Princess Nourah University to enhance scientific research, support pharmaceutical innovation, and develop national competencies in the drug manufacturing sector.
Sudair Pharma CEO Participates in Saudi–US Investment Forum to Discuss the Future of Healthcare Innovation

Sudair Pharma’s CEO Dr. Yasser Alobaidaa participated in the Saudi–US Investment Forum to discuss innovation in health technologies and the importance of global partnerships in shaping the future of healthcare.
Sudair Pharma has signed a collaboration agreement with the College of Pharmacy at Qassim University, marking a significant step toward developing the next generation of national pharmaceutical professionals.

Sudair Pharma signed a collaboration agreement with the College of Pharmacy at Qassim University to develop national pharmaceutical talent and strengthen investment in human capital.
Sudair Pharma Signs MoU with AWS and SUDO Consultants to Advance Digital Transformation

Sudair Pharma signed a Memorandum of Understanding with AWS and SUDO Consultants to accelerate digital transformation and strengthen the company’s technological capabilities in the healthcare sector.
Sudair Pharma Participates in BIO 2025 to Advance Global Partnerships and Innovative Therapies

Sudair Pharma participated in BIO 2025, engaging with global biotech and pharmaceutical leaders to advance partnerships and expand access to innovative therapies across the Kingdom and MENA region.
Sudair Pharma Showcases Advanced Pharmaceutical Capabilities at the Saudi Industry Forum 2025

Sudair Pharma participated in the Saudi Industry Forum 2025, highlighting its leadership in pharmaceutical localization, innovation, and national drug security. The company showcased its work in cancer therapies, insulin production, and advanced manufacturing technologies in alignment with Saudi Vision 2030.
Sudair Pharma Welcomes the Ambassador of Ukraine to the Kingdom

Sudair Pharma welcomed His Excellency Anatolii Petrenko, Ambassador of Ukraine to the Kingdom of Saudi Arabia, accompanied by senior officials from MODON. The delegation visited Sudair Pharma’s manufacturing facility to learn about the company’s key localization projects in the pharmaceutical sector.
Sudair Pharma Strengthens Cardiovascular Health Efforts with Active Participation and Strategic Collaboration at the Saudi Heart Association Conference

Sudair Pharma participated in the Saudi Heart Association Conference, showcasing its commitment to cardiovascular health through scientific engagement, community awareness, and a strategic MoU with the Saudi Heart Association to advance joint efforts in education and treatment.
Sudair Pharma CEO Named Among Forbes Middle East Top Healthcare Leaders

Sudair Pharma announced that its Chief Executive Officer has been selected by Forbes Middle East as one of the Top Healthcare Leaders, recognizing his contribution to advancing Saudi pharmaceutical manufacturing and strengthening national healthcare capabilities.